• H. Dunbar Hoskins Jr., MDThe H. Dunbar Hoskins Jr., M.D. Center for Quality Eye Care was established as a quality of care and health policy research center that advances the accessibility to and appropriateness of eye care services. The work of the Hoskins Center will help ensure that patients continue to receive high quality, evidence-based eye care within a tightening economic environment that demands increased value for services provided.

  • from AAO OTAC Refractive Management/Intervention Panel, Hoskins Center for Quality Eye Care
    Femtosecond laser assisted cataract surgery achieves similar refractive and safety outcomes as conventional phacoemulsification cataract surgery.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics/Orbit Panel, Hoskins Center for Quality Eye Care
    Orbital radiation appears to modify the active phase of thyroid eye disease. It may help prevent and treat compressive optic neuropathy, improve motility restriction, and decrease clinical activity in thyroid eye disease.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Adjustable and nonadjustable suture techniques resulted in good surgical outcomes. Most assessed studies reported advantages of adjustable over nonadjustable suture techniques, but the significance and magnitude of these findings are uncertain, and warrant further investigat…
    Ophthalmic Technology Assessment
    from AAO OTAC Retina/Vitreous Panel, Hoskins Center for Quality Eye Care
    Intravitreal anti-VEGF and corticosteroid therapeutics are effective for the treatment of diabetic macular edema. Cataract progression and ocular hypertension are potential adverse events related to corticosteroid therapy. The literature does not conclusively assess comparat…
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Office-based vergence and accommodative therapies improve motor outcomes in children with symptomatic CI, although data are inconsistent regarding symptomatic relief. Evidence is insufficient to determine whether home-based therapies are effective.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Extraocular muscle injection of botulinum toxin type A (BXTA) for horizontal strabismus achieves high rates of successful motor alignment comparable to eye muscle surgery. Limited data are available on comparative sensory outcomes in children for these 2 treatments for strab…
    Ophthalmic Technology Assessment
    from AAO OTAC Refractive Management/Intervention Panel, Hoskins Center for Quality Eye Care
    The evidence reviewed shows no superiority of any single IOL implantation technique in the absence of zonular support. Various techniques provide equivalent outcomes but each technique has its own profile of inherent risk of postoperative complications.
    Ophthalmic Technology Assessment
    from AAO OTAC Glaucoma Panel, Hoskins Center for Quality Eye Care
    Vessel density loss associated with glaucoma can be detected by OCTA. Peripapillary, macular, and choroidal vessel density parameters may complement visual field and structural OCT measurements in the diagnosis of glaucoma.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The current literature does not support the use of topical Arnica montana, vitamin K oxide, R. tomentosum, or Melilotus extract for reducing ecchymosis after oculofacial surgery or pulsed dye laser surgery.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Evidence supports the efficacy and safety of both in-office and facility-based surgery for congenital NLDO. However, treating bilateral NLDO in a facility setting may be better. Because a significant percentage of children achieved resolution spontaneously before 12 months o…
    Ophthalmic Technology Assessment
    from AAO OTAC Refractive Management/Intervention Panel and Hoskins Center for Quality Eye Care
    Calculation methods requiring both prerefractive surgery keratometry and manifest refraction are no longer considered the gold standard. Refractive outcomes of cataract surgery in eyes that had previous excimer laser surgery are less accurate than in eyes that did not.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Despite reports of visual improvement with corticosteroids, optic canal decompression, and medical therapy for indirect TON, the weight of published evidence does not demonstrate a consistent benefit for any of these interventions. In summary, no consensus exists from studie…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Although methodological limitations and potential conflicts of interest in some studies raised concern, the existing body of literature demonstrates improvements in the signs and symptoms of MGD after IPL therapy.
    Ophthalmic Technology Assessment
    from AAO OTAC Cornea and Anterior Segment Disorders Panel, Hoskins Center for Quality Eye Care
    The evidence reviewed shows no superiority of any single IOL implantation technique in the absence of zonular support. The various techniques seem to have equivalent visual acuity outcomes and safety profiles. Each technique has its own profile of inherent risk of postoperat…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Sentinel lymph node biopsy is a promising procedure in patients with eyelid and conjunctival malignancy, and it is useful in identifying sentinel lymph nodes. However, at present, insufficient evidence exists showing that SLNB improves patient outcomes and survival. Recognit…
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Although several imaging methods demonstrated high positive and negative percent agreement with clinical diagnosis, no ophthalmic imaging method conclusively differentiated papilledema from pseudopapilledema in children because of the lack of high-quality evidence.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Cycloplegic autorefraction is appropriate to use in pediatric population-based studies. Cycloplegic retinoscopy can be valuable in individual clinical cases to confirm the accuracy of cycloplegic autorefraction, particularly when corrected visual acuity is worse than expecte…
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The current literature suggests that BADM grafts represent an implantation option for lower eyelid retraction repair. Short-term results are favorable, and the materials used may fill an important gap in care for patients for whom no acceptable alternatives exist.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    No level I evidence supports the use of binocular treatment as a substitute for current therapies for amblyopia (including patching and optical treatment). Two large randomized controlled trials showed inferior performance compared with standard patching treatment.
    Ophthalmic Technology Assessment
    from AAO OTAC Cornea and Anterior Segment Disorders Panel, Hoskins Center for Quality Eye Care
    Conclusions are limited owing to the absence of controlled trials. The literature suggest that autologous serum-based tears is a reasonable option in refractory cases of dry eyes or nonhealing epithelial defects.
    Ophthalmic Technology Assessment